Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

CYduct Diagnostics, Inc. (CYDX)

Compare
0.2021
0.0000
(0.00%)
At close: April 18 at 4:00:00 PM EDT
Loading Chart for CYDX
  • Previous Close 0.0000
  • Open 0.2021
  • Bid 0.2031 x --
  • Ask 0.5080 x --
  • Day's Range 0.2021 - 0.2021
  • 52 Week Range 0.1270 - 0.5320
  • Volume 23
  • Avg. Volume 29
  • Market Cap (intraday) 1.059M
  • Beta (5Y Monthly) -1.47
  • PE Ratio (TTM) 0.26
  • EPS (TTM) 0.7680
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

CYduct Diagnostics, Inc., a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions. The company's products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps. It also offers insufflators; laparoscopic instruments, such as general surgery, lymphadenectomy, gynecology, and thorascopy instruments; rigid scopes and accessories, including laparoscopes, operative scopes, cystoscopes, and scope trays; trocar and cannula sets, cannulas, trocars, reducer sleeves, and seals; video carts; instrument handles that include insulated handles and non-insulated handles; and veterinary instrumentation. The company was formerly known as Solos Endoscopy, Inc. and changed its name to CYduct Diagnostics, Inc. in December 2020. CYduct Diagnostics, Inc. was founded in 1986 and is based in Westport, Connecticut.

cyductdx.com

3

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CYDX

View More

Performance Overview: CYDX

Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CYDX
32.87%
S&P 500 (^GSPC)
10.18%

1-Year Return

CYDX
32.63%
S&P 500 (^GSPC)
5.42%

3-Year Return

CYDX
71.93%
S&P 500 (^GSPC)
20.29%

5-Year Return

CYDX
66.32%
S&P 500 (^GSPC)
83.77%

Compare To: CYDX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CYDX

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    1.06M

  • Enterprise Value

    1.06M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    39.59%

  • Return on Assets (ttm)

    -13.61%

  • Return on Equity (ttm)

    8.39%

  • Revenue (ttm)

    344.78k

  • Net Income Avi to Common (ttm)

    136.51k

  • Diluted EPS (ttm)

    0.7680

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.33k

  • Total Debt/Equity (mrq)

    8.82%

  • Levered Free Cash Flow (ttm)

    -541.37k

Research Analysis: CYDX

View More

Company Insights: CYDX

Research Reports: CYDX

View More

People Also Watch